--- title: Cry Detection AI 1.0 clears first clinical acceptance gate at Radboudumc – Nijmegen description: In August 2022, Neolook's Cry Detection 1.0 passed a formal clinical acceptance test at Radboudumc – Beatrix Kinderziekenhuis under live NICU conditions – the first formal AI clinical gate cleared by Neolook in an academic neonatal centre. image: https://www.neolooksolutions.com/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png --- [Zu Content springen](https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen#main-content) ![Neolook_logo_RGB_FCMark-1](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook_logo_RGB_FCMark-1.png?width=200&height=152&name=Neolook_logo_RGB_FCMark-1.png "Neolook_logo_RGB_FCMark-1") Neolook Uniting those who care Digital eyes and ears on the child in intensive care. Always. Deutsch - [Nederlands](https://www.neolooksolutions.com/nl/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen) - [English](https://www.neolooksolutions.com/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen) - [Deutsch](https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen) [Contact us](https://www.neolooksolutions.com/contact-us?hsLang=de) [Home](https://www.neolooksolutions.com/?hsLang=de) [Products](https://www.neolooksolutions.com/products?hsLang=de) [Plans](https://www.neolooksolutions.com/plans?hsLang=de) [Enquiry](https://www.neolooksolutions.com/enquiry?hsLang=de) [Media](https://www.neolooksolutions.com/media?hsLang=de) [Blog](https://www.neolooksolutions.com/blog?hsLang=de) [About Us](https://www.neolooksolutions.com/about-us?hsLang=de) Dies ist ein Suchfeld mit einer automatischen Vorschlagsfunktion. - Es gibt keine Vorschläge, da das Suchfeld leer ist. 9 Dezember 2022 # Cry Detection AI 1.0 clears first clinical acceptance gate at Radboudumc – Nijmegen [Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata) Teilen: [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen) [envelope icon](mailto:?body=https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen) In August 2022, Neolook's Cry Detection 1.0 prototype passed a formal acceptance-test protocol at Radboudumc – Beatrix Kinderziekenhuis, one of the Netherlands' eight university medical centres. The prototype was evaluated against pre-specified detection-accuracy criteria under live NICU conditions and met all requirements, clearing the gate to production testing. The test followed a deal won through a three-week demonstrator sprint in December 2021 and preceded the successful production test eight weeks later (October 2022). Together, 2022 delivered a complete acceptance-to-production validation cycle for Cry Detection 1.0 within a single calendar year – the first formal clinical gate cleared by a Neolook AI module in an academic neonatal centre. [Venture](https://www.neolooksolutions.com/de/blog/tag/venture) ## Verwandte Beiträge [![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png?height=200&name=Neolook%20Logo%20Large%20FC%201160x263.png)](https://www.neolooksolutions.com/de/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=de) [Venture](https://www.neolooksolutions.com/de/blog/tag/venture) ## [Neolook extends single-source EU MDR position: Neolook One and Mira smart sensorheads](https://www.neolooksolutions.com/de/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=de) [Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata) 16 März 2026 Neolook achieved MDR CE for both the Neolook One – its high end smart sensorhead with modular... [Weiterlesen](https://www.neolooksolutions.com/de/blog/neolook-single-source-eu-mdr-position-neolook-one-and-neolook-mira?hsLang=de) [![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png?height=200&name=Neolook%20Logo%20Large%20FC%201160x263.png)](https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor?hsLang=de) [Venture](https://www.neolooksolutions.com/de/blog/tag/venture) ## [Cedars-Sinai invests in Neolook – first US institutional investor](https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor?hsLang=de) [Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata) 11 November 2025 Neolook Solutions B.V., the Dutch neonatal digital health company, has secured USD 525.000 from... [Weiterlesen](https://www.neolooksolutions.com/de/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor?hsLang=de) [![](https://www.neolooksolutions.com/hs-fs/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png?height=200&name=Neolook%20Logo%20Large%20FC%201160x263.png)](https://www.neolooksolutions.com/de/blog/leiden-umc-deploys-s2s-family-2.0-across-17-beds-neolooks-fifth-dutch-hospital-reference?hsLang=de) [Venture](https://www.neolooksolutions.com/de/blog/tag/venture) ## [Leiden UMC deploys S2S Family 2.0 across 17 beds – Neolook's fifth Dutch hospital reference](https://www.neolooksolutions.com/de/blog/leiden-umc-deploys-s2s-family-2.0-across-17-beds-neolooks-fifth-dutch-hospital-reference?hsLang=de) [Marco D'Agata](https://www.neolooksolutions.com/de/blog/author/marco-dagata) 28 September 2023 In June 2023, Leiden UMC completed a full institutional deployment of Neolook's medical-grade S2S... [Weiterlesen](https://www.neolooksolutions.com/de/blog/leiden-umc-deploys-s2s-family-2.0-across-17-beds-neolooks-fifth-dutch-hospital-reference?hsLang=de) #### Our Services - [Home](https://www.neolooksolutions.com) - [Products](https://www.neolooksolutions.com/products) - [Plans](https://www.neolooksolutions.com/plans) - [Media](https://www.neolooksolutions.com/media) - [Blog](https://www.neolooksolutions.com/blog) #### Get In Touch - [Contact](https://www.neolooksolutions.com/contact-us) - [Enquiries](https://www.neolooksolutions.com/enquiry) - [Investors](https://www.neolooksolutions.com/investors) #### Regulatory - [Code of Conduct](https://www.neolooksolutions.com/cookie-statement) - [Terms and Conditions](https://www.neolooksolutions.com/terms-and-conditions) - [Privacy Statement](https://www.neolooksolutions.com/privacy-statement) - [Cookie Statement](https://www.neolooksolutions.com/cookie-statement) - [Disclaimer](https://www.neolooksolutions.com/disclaimer) Neolook Solutions BV Princetonlaan 6, 3584 CB Utrecht The Netherlands Chamber of Commerce 77050797      Copyright © 2020-2026, Neolook Solutions ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Marco D'Agata", "url" : "https://www.neolooksolutions.com/de/blog/author/marco-dagata" }, "dateModified" : "2026-05-03T10:59:36.205Z", "datePublished" : "2022-12-09T11:00:00.000Z", "headline" : "Cry Detection AI 1.0 clears first clinical acceptance gate at Radboudumc – Nijmegen", "image" : [ "https://www.neolooksolutions.com/hubfs/Neolook%20Logo%20Large%20FC%201160x263.png" ], "mainEntityOfPage" : { "@id" : "https://www.neolooksolutions.com/de/blog/cry-detection-ai-1.0-clears-first-clinical-acceptance-gate-at-radboudumc-nijmegen", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.neolooksolutions.com/hubfs/Neolook_logo_RGB_FCMark-1.png" }, "name" : "Neolook Solutions" } } ```